There’s a good chance you or someone you love will struggle with kidney stones. The condition affects about 1 out of 11 people during their lifetime. While some people pass stones with little to no difficulty, others suffer with immense pain, bleeding or further complications. David Goldfarb, M.D. suffered through a particularly tough case and it inspired him to help others struggling with the condition.
The NYU-Langone School of Medicine professor will conduct a Facebook Live session about kidney stones and how to treat them on Wednesday, March 11th from 5 to 6 p.m. EDT. Those in the virtual audience will be able to ask Goldfarb questions about the condition and its management. Session participants also can win a prize package from Moonstone Kidney Health Beverage. To be eligible to win, participants must be residents of the United States, be age 18 or older and participate in the event’s comment feed. Three prize packages will be awarded.
Facebook Live Kidney Health Q and A
March 11th from 5 to 6pm EDT
Dr. David Goldfarb
Moonstone is the first beverage scientifically designed to support kidney health. The patented drink is made with 30mEq of alkali-bound citrate, the only citrate proven to reduce kidney stones formation in most people. Moonstone is available as a great-tasting ready-to-drink beverage and as a convenient drink mix.
Goldfarb is an acclaimed expert on kidney health. In addition to teaching kidney physiology at NYU School of Medicine and seeing patients who have a variety of kidney stones, Goldfarb has held several leadership positions in nephrology, the branch of medicine that focuses on kidney care.
He serves on the medical advisory board of the National Kidney Foundation serving Greater New York, the scientific advisory board of the Oxalosis and Hyperoxaluria Foundation, and the board of directors of the International Cystinuria Foundation.
He is the principal investigator of the Rare Kidney Stone Consortium’s Cystinuria Project, which is funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Advancing Translational Sciences.
Previously, Goldfarb served as the associate editor of the Clinical Journal of the American Society of Nephrology for five years, and was the president of the Research on Calculus Kinetics Society (the R.O.C.K. Society) and the New York Society of Nephrology. He also served as vice chair of the American Urological Association’s guideline panel on the medical management of kidney stones, representing the American Society of Nephrology.
He was named “Stone Crusher of the Year” by the Oxalosis and Hyperoxaluria Foundation in 2014 and “Nephrologist of the Year” by the American Kidney Fund in 2016.